U.S. Capital Markets Stock News

Quaker Chemical (KWR) opened 2026 with Q1 revenue of US$480.5 million and basic EPS of US$1.14, with the latest trailing twelve month figures showing revenue of about US$1.9 billion and basic EPS of US$0.25. Over recent quarters, revenue has moved from US$442.9 million and EPS of US$0.73 in Q1 2025 to US$444.1 million and EPS of US$0.80 in Q4 2024, before reaching US$480.5 million and EPS of US$1.14 in the latest quarter. This has occurred against a backdrop of trailing net income that has...

Hippo Holdings (HIPO) opened 2026 with Q1 revenue of US$121.5 million and basic EPS of US$0.27, alongside trailing twelve month revenue of US$479.6 million and EPS of US$4.42. Over the past four reported quarters, revenue has moved from US$397.3 million to US$479.6 million on a trailing basis, while EPS shifted from a trailing loss of US$1.64 to EPS of US$4.42. This puts the focus on how durable that earnings profile really is. The latest quarter keeps attention squarely on margins and the...

If you are wondering whether Dycom Industries is still reasonably priced after a strong run, or if the stock is starting to look stretched, this article walks through what the current market price could be implying. Dycom’s share price recently closed at US$433.60, with reported returns of 5.6% over the past week, 24.8% over the last month, 24.8% year to date, 140.2% over 1 year, 354.5% over 3 years and 339.1% over 5 years. Recent coverage has focused on Dycom’s role as a specialty...

Latest quarterly snapshot TFS Financial (TFSL) has just posted Q2 2026 results with total revenue of US$85.2 million and basic EPS of US$0.08, setting the tone for how investors will read the latest quarter. The company has seen revenue move from US$77.6 million in Q2 2025 to US$85.2 million in Q2 2026, while quarterly EPS has ranged between about US$0.07 and US$0.09 over the last six reported periods. This gives a clear view of how the top and bottom line have tracked together. With trailing...

AptarGroup (ATR) opened 2026 with Q1 revenue of US$982.9 million and basic EPS of US$1.13, while trailing twelve month revenue stood at US$3.9 billion and EPS at US$5.93, setting a clear benchmark for the latest quarter against its recent run rate. Over the past five reported quarters, revenue has moved from US$887.3 million in Q1 2025 to US$982.9 million in Q1 2026, with quarterly EPS ranging between US$1.13 and US$1.95 over that stretch. This gives investors a consistent view of how the top...

If you are wondering whether Baker Hughes at around US$69.12 is still reasonable value or if you are arriving late to the story, this article will help you frame that question clearly. The stock has posted returns of 0.3% over 7 days, 14.6% over 30 days, 46.6% year to date and 90.1% over the last year, which naturally raises questions about how much of the value case is already reflected in the price. Recent coverage has focused on Baker Hughes as a key energy services name during a period...

Viking Therapeutics (VKTX) has moved deeper into late stage obesity drug development, completing enrollment in its Phase 3 VANQUISH-1 and VANQUISH-2 trials for injectable VK2735 and outlining plans for an oral Phase 3 program. See our latest analysis for Viking Therapeutics. The wider Q1 loss, as R&D spending ramped for Phase 3 obesity programs, appears to be weighing on sentiment in the short term, with a 1 month share price return decline of 8.98% and a year to date share price return...

Zeta Global Holdings (ZETA) Q1 2026 earnings snapshot Zeta Global Holdings (ZETA) opened 2026 with Q1 revenue of US$396.3 million and a basic EPS loss of US$0.05 per share, while the trailing 12 month figures show US$1.4 billion of revenue and a net loss of US$23.2 million. Over the past five reported quarters, revenue has moved from US$264.4 million in Q1 2025 to US$396.3 million in Q1 2026, while basic EPS has ranged between a loss of US$0.10 and a profit of US$0.07 per share across that...

Wondering whether McEwen's current share price reflects its real worth, or if the stock is getting ahead of itself. The share price last closed at US$21.30, with returns of 14.0% year to date and 189.4% over the past year, while the last 7 days saw a 12.2% decline and the last 30 days were flat at a 0.5% decline. Recent coverage has focused on McEwen's strong one year return of 189.4%. This stands out against its more moderate 3 year and 5 year returns of 138.8% and 63.8%. This context...

Piedmont Realty Trust (PDM) opened 2026 with Q1 revenue of US$143.3 million and basic EPS of a US$0.10 loss, while trailing 12 month revenue was US$565.6 million and EPS was a US$0.69 loss. Over the past year, the company’s quarterly revenue moved from US$142.7 million in Q1 2025 to US$143.3 million in Q1 2026, with basic EPS shifting from a Q1 2025 loss of US$0.08 per share to a Q1 2026 loss of US$0.10 per share as investors consider how these margins may influence any potential...

Investors may be wondering whether Chemed, at around US$422 per share, still lines up with its underlying worth or if the recent price is out of step with fundamentals. Over the last month the stock is up 11.8%, even though the 1 year return sits at a 26.3% decline and the year to date return is roughly flat at a 0.4% decline. Recent coverage around Chemed has focused on its role in healthcare services and how investors are weighing that profile against a weaker 1 year share price...

Mohawk Industries (MHK) opened 2026 with Q1 revenue of US$2.7 billion and basic EPS of US$1.91, setting the tone for how investors weigh the latest numbers against trailing profitability and growth expectations. Over the past few quarters, revenue has moved between US$2.5 billion in Q1 2025 and US$2.8 billion in Q2 2025, while basic EPS ranged from US$0.68 in Q4 2025 to US$2.35 in Q2 2025, providing a view of how earnings have tracked relative to a fairly steady top line. With trailing net...

nLIGHT (NasdaqGS:LASR) is expanding its operations in Torino, Italy to support rising regional demand for directed energy and high power laser solutions. The move is intended to serve European and allied customers with regionally tailored products and improve localization and supply chain resilience. This expansion marks a material step in nLIGHT's international build out and its focus on defense related laser technologies. For investors tracking nLIGHT, the expansion comes with the shares...

Next Technology Holding (NasdaqCM:NXTT) opened 2026 with Q1 revenue of about US$0.5 million and a basic EPS loss of US$1.39 per share, alongside a net loss of US$105.9 million. Over recent quarters the company has seen revenue move from US$0 in Q1 2025 to US$9.8 million in Q4 2025 before landing at US$0.5 million in Q1 2026. EPS has swung from a very high profit of US$396.38 per share in Q1 2025 to a loss of US$1.39 in the latest quarter, setting a backdrop where reported margins look highly...

Brookfield Infrastructure (NYSE:BIPC) has opened 2026 with Q1 revenue of US$884 million and a basic EPS loss of US$0.93, setting the tone for another quarter where the income statement matters more than headline growth stories. Over the past year, quarterly revenue has ranged from US$866 million to US$956 million while EPS has swung between a gain of US$3.27 and a loss of US$4.01, highlighting how volatile profitability has been for shareholders watching margins. See our full analysis for...

Wondering whether Blackbaud at around US$37.54 is a bargain or a value trap? This breakdown will help you size up what the current share price really reflects. The stock has been broadly flat over the last month at around 0.0%. However, that sits against a much tougher backdrop with a 36.9% decline year to date and a 38.9% decline over the past year. Those longer term returns mean many holders are sitting on losses, which often pushes valuation questions to the front of investors' minds...

Pro-Dex (PDEX) has put up a solid Q3 2026 print, with revenue of about US$19.9 million and basic EPS of roughly US$1.23, against a trailing twelve month backdrop where earnings grew 28.1% year over year and net profit margin sat at 16.1%. Over recent quarters the company has seen revenue move from around US$17.4 million in Q3 2025 to US$19.9 million in Q3 2026, while quarterly basic EPS ranged between roughly US$0.37 and US$1.43 over that stretch, giving a clear view of how revenue and per...

American International Group (AIG) opened 2026 with Q1 results that put the focus squarely on the income statement, as revenue came in at US$6.7b and basic EPS landed at US$1.42 on net income of US$763m. The company has seen revenue move from US$6.5b in Q1 2025 to US$6.7b in Q1 2026, while basic EPS over that stretch ranged from US$1.18 in Q1 2025 to US$1.42 in the latest quarter. This sets the stage for investors to weigh these headline figures against a backdrop of improving trailing net...

OneSpan (OSPN) Q1 2026 earnings snapshot OneSpan (OSPN) has opened 2026 with Q1 revenue of US$65.9 million and basic EPS of US$0.31, setting the tone for investors assessing how the business is converting its software demand into bottom line results. Over the past year, the company has seen trailing twelve month revenue sit at US$245.8 million with basic EPS of US$1.84, alongside earnings growth of 20.4% and net margins at 28.5% compared to 24% a year earlier. This provides useful context for...

LPL Financial Holdings (LPLA) opened 2026 with Q1 revenue of about US$4.8b and basic EPS of US$4.45, as investors weigh these headline figures against a reported net margin of 5% over the trailing 12 months that was affected by a US$732.0m one off loss. The company has seen quarterly revenue move from US$3.4b in Q4 2024 to US$3.6b in Q1 2025 and then to about US$4.8b in Q1 2026. Over the last six reported periods, trailing 12 month basic EPS has ranged from US$14.17 to US$11.25, placing...

Jade Biosciences (NasdaqCM: JBIO) appointed Edward R. Conner, M.D. as Chief Medical Officer. The company elevated Andrew King, M.D., Ph.D. to President, Research & Development. These leadership changes focus on clinical development, regulatory strategy, and R&D continuity for Jade's autoimmune pipeline. Jade Biosciences, listed on NasdaqCM under the ticker JBIO, is focused on developing therapies for autoimmune conditions, an area that continues to attract capital and partnerships across...

PBF Energy (PBF) opened 2026 with Q1 revenue of US$7.9b and basic EPS of US$1.69, alongside net income excluding extra items of US$198.3m, setting a clear marker after a volatile run of recent quarters. The company has seen quarterly revenue move from US$7.1b in Q1 2025 to US$7.9b in Q1 2026, while EPS shifted from a loss of US$3.53 in Q1 2025 to a profit of US$1.69 in the latest period. This points to a very different margin profile as investors gauge how durable this reset may be. See our...

Wondering whether Delta Air Lines at around US$68.98 is offering good value or stretching expectations? This article will help you size up the stock through a clear valuation lens. The share price has moved by 0.8% over the last 7 days and 2.0% over the last 30 days, with a 1 year return of 58.0% and a 3 year return of 109.5%, while the year to date figure sits at a slight 0.1% decline. Recent headlines have focused on Delta Air Lines in the context of broader airline sector themes,...

Investors may be wondering whether Aurora Innovation's share price reflects its true worth, or if the market is mispricing the story right now. The stock recently closed at US$6.13, with returns of 24.8% over 7 days, 46.7% over 30 days, 58.4% year to date, and a 24.7% decline over the past year, alongside a very large gain over 3 years. Recent coverage has focused on how autonomous driving and AI related names are being reassessed by investors, as attention shifts to companies tied to real...